Niacin and Carcinogenesis

Nutrition and Cancer

Volumn 46, Issue 2, 2003, Pages 110-118

  Kirkland, James B ^a  

^a UNIVERSITY OF GUELPH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE RIBOSE; DNA; GUANINE NUCLEOTIDE BINDING PROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; NICOTINIC ACID; NICOTINIC ACID ADENINE DINUCLEOTIDE PHOSPHATE; POLY(ADENOSINE DIPHOSPHATE RIBOSE); PROTEIN P53; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE;

ADENOSINE DIPHOSPHATE RIBOSYLATION; ANIMAL MODEL; APOPTOSIS; CANCER; CANCER INCIDENCE; CELL CYCLE; DIETARY INTAKE; DNA REPAIR; EXCISION REPAIR; GENE EXPRESSION REGULATION; GENOME; HUMAN; LEUKEMIA; LEUKEMOGENESIS; MITOSIS; NICOTINIC ACID DEFICIENCY; NONHUMAN; NUTRITIONAL DEFICIENCY; REVIEW; SKIN CANCER; SKIN CARCINOGENESIS; TELOMERE;

ANIMALIA;

EID: 0344197087     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1207/S15327914NC4602_02     Document Type: Review

References (87)

1. Kirkland JB and Rawling JM: Niacin. In Handbook of Vitamins, Rucker RB, Suttie JW, McCormick DB, and Machlin LJ (eds). New York: Marcel Decker, 2001, pp 211-252.
2. Jacobson EL: Niacin deficiency and cancer in women. J Am Coll Nutr 12, 412-416, 1993.
3. Essama-Tjani JC, Guilland JC, Fuchs F, Lombard M, and Richard D: Changes in thiamin, riboflavin, niacin, beta-carotene, vitamins, C, A, D and E status of French elderly subjects during the first year of institutionalization. Int J Vitam Nutr Res 70, 54-64, 2000.
4. Inculet RI, Norton JA, Nichoalds GE, Maher MM, White DE, et al.: Water-soluble vitamins in cancer patients on parenteral nutrition: a prospective study. J Parenter Enteral Nutr 11, 243-249, 1987.
5. Dreizen S, McCredie KB, Keating MJ, and Andersson BS: Nutritional deficiencies in patients receiving cancer chemotherapy. Postgrad Med 87, 163-167, 170, 1990.
6. Felix CA: Secondary leukemias induced by topoisomerase-targeted drugs. Biochim Biophys Acta 1400, 233-255, 1998.
7. Boyonoski AC, Spronck JC, Gallacher LM, Jacobs RM, Shah GM, et al.: Niacin deficiency decreases bone marrow poly(ADP-ribose) and the latency of ethylnitrosourea-induced carcinogenesis in rats. J Nutr 132, 108-114, 2002.
8. Jacobson EL, Dame AJ, Pyrek JS, and Jacobson MK: Evaluating the role of niacin in human carcinogenesis. Biochimie 77, 394-398, 1995.
9. Blot WJ, Li JY, Taylor PR, Guo W, Dawsey S, et al.: Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population [see comments]. J Natl Cancer Inst 85, 1483-1492, 1993.
10. Wang H, Wei H, Ma J, and Luo X: The fumonisin B1 content in com from North China, a high-risk area of esophageal cancer. J Environ Pathol Toxicol Oncol 19, 139-141, 2000.
11. Riley RT, Enongene E, Voss KA, Norred WP, Meredith FI, et al.: Sphingolipid perturbations as mechanisms for fumonisin carcinogenesis. Environ Health Perspect 109 Suppl 2, 301-308, 2001.
12. Kritchevsky SB and Kritchevsky D: Serum cholesterol and cancer risk: an epidemiologic perspective. Annu Rev Nutr 12, 391-416, 1992.
13. Canner PL, Berge KG, Wenger NK, Stamler J, Friedman L, et al.: Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin. J Am Coll Cardiol 8, 1245-1255, 1986.
14. Franceschi S, Bidoli E, Baron AE, and La Vecchia C: Maize and risk of cancers of the oral cavity, pharynx, and esophagus in northeastern Italy. J Natl Cancer Inst 82, 1407-1411, 1990.
15. Slattery ML, Potter JD, Coates A, Ma KN, Berry TD, et al.: Foods and colon cancer: an assessment of specific foods and their related nutrients (United States). Cancer Causes Control 8, 575-590, 1997.
16. Harrison LE, Zhang ZF, Karpeh MS, Sun M, and Kurtz RC: The role of dietary factors in the intestinal and diffuse histologic subtypes of gastric adenocarcinoma: a case-control study in the U.S. Cancer 80, 1021-1028, 1997.
17. Negri E, Franceschi S, Bosetti C, Levi F, Conti E, et al.: Selected micronutrients and oral and pharyngeal cancer. Int J Cancer 86, 122-127, 2000.
18. Siassi F, Pouransari Z, and Ghadirian P: Nutrient intake and esophageal cancer in the Caspian littoral of Iran: a case-control study. Cancer Detect Prev 24, 295-303, 2000.
19. Van Rensburg SJ, Bradshaw ES, Bradshaw D, and Rose EF: Oesophageal cancer in Zulu men, South Africa: a case-control study. Br J Cancer 51, 399-405, 1985.
20. Segal I, Hale M, Demetriou A, and Mohamed AE: Pathological effects of pellagra on the esophagus. Nutr Cancer 14, 233-238, 1990.
21. Shah GM, Le Rhun Y, Sutarjono I, and Kirkland JB: Niacin deficient SKH-1 mice are more susceptible to ultraviolet B radiation-induced skin carcinogenesis. Cancer Res 131 Suppl, 3150S, 2002.
22. Cleaver JE and Crowley E: UV damage, DNA repair and skin carcinogenesis. Front Biosci 7, d1024-d1043, 2002.
23. Bryan GT: The influence of niacin and nicotinamide on in vivo carcinogenesis. In Advances in Experimental Medicine and Biology Vol 206 - Essential Nutrients in Carcinogenesis, Poirier LA, Newberne PM, and Pariza MW (eds). New York: Plenum Press, 1986, pp 331-338.
24. Toth B. Lack of carcinogenicity of nicotinamide and isonicotinamide following lifelong administration to mice. Oncology 40, 72-75, 1983.
25. Rawling JM, Jackson TM, Roebuck BD, Poirier GG, and Kirkland JB: The effect of niacin deficiency on diethylnitrosamine-induced hepatic poly(ADP-ribose) levels and altered hepatic foci in the Fischer-344 rat. Nutr Cancer 24, 111-119, 1995.
26. Rawling JM, ApSimon MM, and Kirkland JB: Lung poly(ADP-ribose) and NAD+ concentrations during hyperoxia and niacin deficiency in the Fischer-344 rat. Free Radic Biol Med 20, 865-871, 1996.
27. Boyonoski AC, Gallacher LM, ApSimon MM, Jacobs RM, Shah GM, et al.: Niacin deficiency in rats increases the severity of ethylnitrosourea-induced anemia and leukopenia. J Nutr 130, 1102-1107, 2000.
28. Boyonoski AC, Spronck JC, Jacobs RM, Shah GM, Poirier GG, et al.: Pharmacological intakes of niacin increase bone marrow poly(ADP-ribose) and the latency of ethylnitrosourea-induced carcinogenesis in rats. J Nutr 132, 115-120, 2002.
29. Spronck JC and Kirkland JB: Niacin deficiency increases spontaneous and etoposide-induced chromosomal instability in rat bone marrow cells in vivo. Mutat Res 508, 83-97, 2002.
30. Gensler HL, Williams T, Huang AC, and Jacobson EL: Oral niacin prevents photocarcinogenesis and photoimmunosuppression in mice. Nutr Cancer 34, 36-41, 1999.
31. Partida-Sanchez S, Randall TD, and Lund FE: Innate immunity is regulated by CD38, an ecto-enzyme with ADP-ribosyl cyclase activity. Microbes Infect 5, 49-58, 2003.
32. Bemeburg M and Lehmann AR: Xeroderma pigmentosum and related disorders: defects in DNA repair and transcription. Adv Genet 43, 71-102, 2001.
33. Lautier D, Lagueux J, Thibodeau J, Menard L, and Poirier GG: Molecular and biochemical features of poly (ADP-ribose) metabolism. Mol Cell Biochem 122, 171-193, 1993.
34. Satoh MS, Poirier GG, and Lindahl T: NAD(+)-dependent repair of damaged DNA by human cell extracts. J Biol Chem 268, 5480-5487, 1993.
35. Shieh WM, Ame JC, Wilson MV, Wang ZQ, Koh DW, et al.: Poly(ADP-ribose) polymerase null mouse cells synthesize ADP-ribose polymers. J Biol Chem 273, 30069-30072, 1998.
36. Ame JC, Rolli V, Schreiber V, Niedergang C, Apiou F, et al.: PARP-2, A novel mammalian DNA damage-dependent poly(ADP-ribose) polymerase. J Biol Chem 274, 17860-17868, 1999.
37. Johansson M: A human poly(ADP-ribose) polymerase gene family (ADPRTL): cDNA cloning of two novel poly(ADP-ribose) polymerase homologues. Genomics 57, 442-445, 1999.
38. Kickhoefer VA, Siva AC, Kedersha NL, Inman EM, Ruland C, et al.: The 193-kD vault protein, VPARP, is a novel poly(ADP-ribose) polymerase. J Cell Biol 146, 917-928, 1999.
39. Smith S, Giriat I, Schmitt A, and de Lange T: Tankyrase, a poly(ADP-ribose) polymerase at human telomeres. Science 282, 1484-1487, 1998.
40. Meli E, Pangallo M, Baronti R, Chiarugi A, Cozzi A, et al.: Poly(ADP-ribose) polymerase as a key player in excitotoxicity and post-ischemic brain damage. Toxicol Lett 139, 153-162, 2003.
41. Schreiber V, Ame JC, Dolle P, Schultz I, Rinaldi B, et al.: Poly(ADP-ribose) polymerase-2 (PARP-2) is required for efficient base excision DNA repair in association with PARP-1 and XRCC1. J Biol Chem 277, 23028-23036, 2002.
42. Menissier dM, Ricoul M, Tartier L, Niedergang C, Huber A, et al.: Functional interaction between PARP-1 and PARP-2 in chromosome stability and embryonic development in mouse. EMBO J 22, 2255-2263, 2003.
43. Smith S and de Lange T: Tankyrase promotes telomere elongation in human cells [in process citation]. Curr Biol 10, 1299-1302, 2000.
44. Kaminker PG, Kim SH, Taylor RD, Zebarjadian Y, Funk WD, et al.: Tank2, a new trfl-associated poly(adp-ribose) polymerase, causes rapid induction of cell death upon overexpression. J Biol Chem 276, 35891-35899, 2001.
45. Kanai M, Uchida M, Hanai S, Uematsu N, Uchida K, et al.: Poly(ADP-ribose) polymerase localizes to the centrosomes and chromosomes. Biochem Biophys Res Commun 278, 385-389, 2000.
46. Smith S and de Lange T: Cell cycle dependent localization of the telomeric PARP, tankyrase, to nuclear pore complexes and centrosomes. J Cell Sci 112, 3649-3656, 1999.
47. Bernstein C, Bernstein H, Payne CM, and Garewal H: DNA repair/pro-apoptotic dual-role proteins in five major DNA repair pathways: fail-safe protection against carcinogenesis. Mutat Res 511, 145-178, 2002.
48. Durkacz BW, Omidiji O, Gray DA, and Shall S: (ADP-ribose)n participates in DNA excision repair. Nature 283, 593-596, 1980.
49. Jacobson EL, Nunbhakdi-Craig V, Smith DG, Chen HY, Wasson BL, et al.: ADP-ribose polymer metabolism: implications for human nutrition. In ADP-Ribosylation Reactions, Poirier GG and Moreau P (eds). New York: Springer-Verlag, 1992, pp 153-162.
50. Molinete M, Vermeulen W, Burkle A, Menissier-de Murcia J, Kupper JH, et al.: Overproduction of the poly(ADP-ribose) polymerase DNA-binding domain blocks alkylation-induced DNA repair synthesis in mammalian cells. EMBO J 12, 2109-2117, 1993.
51. Vodenicharov MD, Sallmann FR, Satoh MS, and Poirier GG: Base excision repair is efficient in cells lacking poly(ADP-ribose) polymerase 1. Nucleic Acids Res 28, 3887-3896, 2000.
52. Dantzer F, de La RG, Menissier-de Murcia J, Hostomsky Z, de Murcia G, et al.: Base excision repair is impaired in mammalian cells lacking poly(ADP-ribose) polymerase-1. Biochemistry 39, 7559-7569, 2000.
53. Le Rhun Y, Kirkland JB, and Shah GM: Cellular responses to DNA damage in the absence of poly(ADP-ribose) polymerase. Biochem Biophys Res Commun 245, 1-10, 1998.
54. Tsutsumi M, Masutani M, Nozaki T, Kusuoka O, Tsujiuchi T, et al: Increased susceptibility of poly(ADP-ribose) polymerase-1 knockout mice to nitrosamine carcinogenicity. Carcinogenesis 22, 1-3, 2001.
55. Oikawa A, Tohda H, Kanai M, Miwa M, and Sugimura T: Inhibitors of poly(adenosine diphosphate ribose) polymerase induce sister chromatid exchanges. Biochem Biophys Res Commun 97, 1311-1316, 1980.
56. Schreiber V, Hunting D, Trucco C, Gowans B, Grunwald D, et al.: A dominant-negative mutant of human poly(ADP-ribose) polymerase affects cell recovery, apoptosis, and sister chromatid exchange following DNA damage. Proc Natl Acad Sci USA 92, 4753-4757, 1995.
57. Wang ZQ, Stingl L, Morrison C, Jantsch M, Los M, et al.: PARP is important for genomic stability but dispensable in apoptosis. Genes Dev 11, 2347-2358, 1997.
58. Oren M: Decision making by p53: life, death and cancer. Cell Death Differ 10, 431-442, 2003.
59. Brooks CL and Gu W: Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation. Curr Opin Cell Biol 15, 164-171, 2003.
60. Simbulan-Rosenthal CM, Rosenthal DS, Luo R, and Smulson ME: Poly(ADP-ribosyl)ation of p53 during apoptosis in human osteosarcoma cells. Cancer Res 59, 2190-2194, 1999.
61. Whitacre CM, Hashimoto H, Tsai ML, Chatterjee S, Berger SJ, et al.: Involvement of NAD-poly(ADP-ribose) metabolism in p53 regulation and its consequences. Cancer Res 55, 3697-3701, 1995.
62. Wesierska-Gadek J, Wang ZQ, and Schmid G: Reduced stability of regularly spliced but not alternatively spliced p53 protein in PARP-deficient mouse fibroblasts. Cancer Res 59, 28-34, 1999.
63. Agarwal ML, Agarwal A, Taylor WR, Wang ZQ, Wagner EF, et al.: Defective induction but normal activation and function of p53 in mouse cells lacking poly-ADP-ribose polymerase. Oncogene 15, 1035-1041, 1997.
64. Wang X, Ohnishi K, Takahashi A, and Ohnishi T: Poly(ADP-ribosyl)ation is required for p53-dependent signal transduction induced by radiation. Oncogene 17, 2819-2825, 1998.
65. Schmid G, Wang ZQ, and Wesierska-Gadek J: Compensatory expression of p73 in PARP-deficient mouse fibroblasts as response to a reduced level of regularly spliced wild-type p53 protein. Biochem Biophys Res Commun 255, 399-405, 1999.
66. Masutani M, Nozaki T, Nishiyama E, Shimokawa T, Tachi Y, et al.: Function of poly(ADP-ribose) polymerase in response to DNA damage: gene-disruption study in mice. Mol Cell Biochem 193, 149-152, 1999.
67. Vaziri H, West MD, Allsopp RC, Davison TS, Wu YS, et al.: ATM-dependent telomere loss in aging human diploid fibroblasts and DNA damage lead to the post-translational activation of p53 protein involving poly(ADP-ribose) polymerase. EMBO J 16, 6018-6033, 1997.
68. Nozaki T, Masutani M, Akagawa T, Sugimura T, and Esumi H: Suppression of G1 arrest and enhancement of G2 arrest by inhibitors of poly(ADP-ribose) polymerase: possible involvement of poly(ADP-ribosyl)ation in cell cycle arrest following gamma-irradiation. Jpn J Cancer Res 85, 1094-1098, 1994.
69. Masutani M, Nozaki T, Wakabayashi K, and Sugimura T: Role of poly(ADP-ribose) polymerase in cell-cycle checkpoint mechanisms following gamma-irradiation. Biochimie 77, 462-465, 1995.
70. Malanga M, Pleschke JM, Kleczkowska HE, and Althaus FR: Poly(ADP-ribose) binds to specific domains of p53 and alters its DNA binding functions. J Biol Chem 273, 11839-11843, 1998.
71. Wesierska-Gadek J, Bugajska-Schretter A, and Cerni C: ADP-ribosylation of p53 tumor suppressor protein: mutant but not wild-type p53 is modified. J Cell Biochem 62, 90-101, 1996.
72. Kumari SR, Mendoza-Alvarez H, and Alvarez-Gonzalez R: Functional interactions of p53 with poly(ADP-ribose) polymerase (PARP) during apoptosis following DNA damage: covalent poly(ADP-ribosyl)ation of p53 by exogenous PARP and noncovalent binding of p53 to the M(r) 85,000 proteolytic fragment. Cancer Res 58, 5075-5078, 1998.
73. Smulson ME, Simbulan-Rosenthal CM, Boulares AH, Yakovlev A, Stoica B, et al.: Roles of poly(ADP-ribosyl)ation and PARP in apoptosis, DNA repair, genomic stability and functions of p53 and E2F-1. Adv Enzyme Regul 40, 183-215, 2000.
74. Wesierska-Gadek J, Schmid G, and Cerni C: ADP-ribosylation of wild-type p53 in vitro: binding of p53 protein to specific p53 consensus sequence prevents its modification. Biochem Biophys Res Commun 224, 96-102, 1996.
75. Tatematsu K, Nakayama J, Danbara M, Shionoya S, Sato H, et al.: A novel quantitative "stretch PCR assay," that detects a dramatic increase in telomerase activity during the progression of myeloid leukemias. Oncogene 13, 2265-2274, 1996.
76. Preston RJ: Telomeres, telomerase and chromosome stability. Radiat Res 147, 529-534, 1997.
77. d'Adda dF, Hande MP, Tong WM, Lansdorp PM, Wang ZQ, et al.: Functions of poly(ADP-ribose) polymerase in controlling telomere length and chromosomal stability. Nat Genet 23, 76-80, 1999.
78. Samper E, Goytisolo FA, Menissier-de Murcia J, Gonzalez-Suarez E, Cigudosa JC, et al.: Normal telomere length and chromosomal end capping in poly(ADP-ribose) polymerase-deficient mice and primary cells despite increased chromosomal instability. J Cell Biol 154, 49-60, 2001.
79. Halappanavar SS, Rhun YL, Mounir S, Martins LM, Huot J, et al.: Survival and proliferation of cells expressing caspase-uncleavable poly(ADP-ribose) polymerase in response to death-inducing DNA damage by an alkylating agent. J Biol Chem 274, 37097-37104, 1999.
80. Yu SW, Wang HM, Poitras MF, Coombs C, Bowers WJ, et al.: Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor. Science 297, 259-263, 2002.
81. Simbulan-Rosenthal CM, Haddad BR, Rosenthal DS, Weaver Z, Coleman A, et al.: Chromosomal aberrations in PARP(-/-) mice: genome stabilization in immortalized cells by reintroduction of poly(ADP-ribose) polymerase cDNA. Proc Natl Acad Sci USA 96, 13191-13196, 1999.
82. Earle E, Saxena A, MacDonald A, Hudson DF, Shaffer LG, et al.: Poly(ADP-ribose) polymerase at active centromeres and neocentromeres at metaphase. Hum Mol Genet 9, 187-194, 2000.
83. Corda D and Di Girolamo M: Functional aspects of protein mono-ADP-ribosylation. EMBO J 22, 1953-1958, 2003.
84. Lee HC: Physiological functions of cyclic ADP-ribose and NAADP as calcium messengers. Annu Rev Pharmacol Toxicol 41, 317-345, 2001.
85. Landry J, Sutton A, Tafrov ST, Heller RC, Stebbins J, et al.: The silencing protein SIR2 and its homologs are NAD-dependent protein deacetylases. Proc Natl Acad Sci USA 97, 5807-5811, 2000.
86. Lin SJ, Defossez PA, and Guarente L: Requirement of NAD and SIR2 for life-span extension by calorie restriction in Saccharomyces cerevisiae. Science 289, 2126-2128, 2000.
87. Vaziri H, Dessain SK, Eaton EN, Imai SI, Frye RA, et al.: hSir2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell 107, 149-159, 2001.